Início › Acidente Vascular Isquêmico › Texas › Houston
Ensaios clínicos de Acidente Vascular Isquêmico em Houston, TX
17 estudos para Acidente Vascular Isquêmico estão buscando participantes em locais em Houston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecrutandoFase 3
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
- University of Texas Health Science Center at Houston, Houston
Strategy for Improving Stroke Treatment Response
RecrutandoFase 2
- Memorial Hermann Texas Medical Center, Houston
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
Recrutando
- Houston Methodist Hospital, Houston
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RecrutandoFase 2/3
- Corxel Investigational Site, Houston
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
RecrutandoFase 3
- East Texas Cardiology, Houston
- Synergy Group Medical,LLC, Houston
- Synergy Groups Medical, Houston
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
RecrutandoFase 3
- Houston Medical Neurological Institute, Houston
- Memorial Hermann Hospital, Houston
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RecrutandoEstudo observacional
- Houston Methodist Research Institute, Houston
- UTHealth, Houston
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RecrutandoFase 2/3
- Houston Methodist Neurological Institute, Houston
- Memorial Hermann Hospital, Texas Medical Center, Houston
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
RecrutandoEstudo observacional
- Houston Methodist Neurological Institute, Houston
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
RecrutandoEstudo observacional
- Memorial Hermann Texas Medical Center, Houston
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
RecrutandoEstudo observacional
- University of Texas Health Science Center at Houston, Houston
Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy
Recrutando
- University of Texas Health - Houston, Houston
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
RecrutandoFase 2
- Memorial Hermann Hospital, Houston
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Recrutando
- The University of Texas Health Science Center at Houston, Houston
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
RecrutandoFase 3
- HCA Houston Kingwood, Houston
StrokeNet Thrombectomy Endovascular Platform
Recrutando
- Memorial Hermann Texas Medical Center, Houston
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Recrutando
- UTHealth Houston, Houston
Ensaios de Acidente Vascular Isquêmico em outras cidades
- New York City, NY19 estudos
- Boston, MA18 estudos
- Los Angeles, CA15 estudos
- Atlanta, GA14 estudos
- Philadelphia, PA14 estudos
- Chicago, IL13 estudos
- Cincinnati, OH12 estudos
- Baltimore, MD12 estudos
- Pittsburgh, PA11 estudos
- St. Louis, MO11 estudos
- Salt Lake City, UT10 estudos
- Charlottesville, VA10 estudos
Outros estudos em Houston
- Câncer de Pulmão de Não Pequenas Células145 estudos
- Câncer de Mama126 estudos
- Câncer (todos os tipos)122 estudos
- Câncer Metastático104 estudos
- Câncer Colorretal103 estudos
- Câncer de Ovário90 estudos
- Leucemia Mieloide Aguda86 estudos
- Câncer de Pulmão78 estudos
- Câncer de Próstata76 estudos
- Câncer Endometrial69 estudos
- Câncer de Pâncreas62 estudos
- Melanoma59 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.